Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.59 +0.21 (+6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Capital Expenditures (2015 - 2026)

Updated

Insight Molecular Diagnostics' Capital Expenditures came in at $779,000 for Q2 2026, up 123.2% from $349,000 a year earlier and up 27.1% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Capital Expenditures (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Insight Molecular Diagnostics reported Capital Expenditures of $3.92 million, up 309.7% year-over-year; for FY2025, it was $3.19 million, up 517.2% from FY2024.

  • Capital Expenditures carries a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $516,000 in FY2024 (+83.6%), $281,000 in FY2023 (-93.5%), $4.34 million in FY2022 (+93.1%) and $2.25 million in FY2021 (+83.1%).
  • The five-year range for quarterly Capital Expenditures is -$564,000 (Q3 2023) to $1.56 million (Q1 2022).
  • Year-over-year, Capital Expenditures has increased for three consecutive quarters, with growth averaging 175.6% over the last five quarters.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 591.1%), and the weakest in Q4 2023 (a decline of 67.1%).
  • Business Quant data shows IMDX's Capital Expenditures at $613,000 (Q1 2026), $1.48 million (Q4 2025) and $1.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 450.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 497.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 269.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 112.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 503.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 202.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 195.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 66.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 143.00 Mn
10 Insight Molecular Diagnostics 110.27 Mn 33.98 Mn 157,000.00 779,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 779,000.00
Mar 31, 2026 613,000.00
Dec 31, 2025 1.48 Mn
Sep 30, 2025 1.05 Mn
Jun 30, 2025 349,000.00
Mar 31, 2025 307,000.00
Dec 31, 2024 214,000.00
Sep 30, 2024 87,000.00
Jun 30, 2024 191,000.00
Mar 31, 2024 24,000.00
Dec 31, 2023 264,000.00
Sep 30, 2023 -564,000.00
Dec 31, 2022 802,000.00
Sep 30, 2022 859,000.00
Jun 30, 2022 1.12 Mn
Mar 31, 2022 1.56 Mn
Dec 31, 2021 401,000.00
Sep 30, 2021 394,000.00
Jun 30, 2021 610,000.00
Mar 31, 2021 842,000.00
API Access

Insight Molecular Diagnostics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMDX&period=max&api_key=YOUR_API_KEY